Jc. Bloomer et al., CHARACTERIZATION OF THE CYTOCHROME-P450 ENZYMES INVOLVED IN THE IN-VITRO METABOLISM OF GRANISETRON, British journal of clinical pharmacology, 38(6), 1994, pp. 557-566
1 The metabolism of granisetron was investigated in human liver micros
omes to identify the specific forms of cytochrome P450 responsible. 2
7-hydroxy and 9'-desmethyl granisetron were identified as the major pr
oducts of metabolism following incubation of granisetron with human li
ver microsomes. At low, clinically relevant, concentrations of granise
tron the 7-hydroxy metabolite predominated. Rates of granisetron 7-hyd
roxylation varied over 100-fold in the human livers investigated. 3 En
zyme kinetics demonstrated the involvement of at least two enzymes con
tributing to the 7-hydroxylation of granisetron, one of which was a hi
gh affinity component with a K-m of 4 mu M. A single, low affinity, en
zyme was responsible for the 9'-desmethylation of granisetron. 4 Grani
setron caused no inhibition of any of the cytochrome P450 activities i
nvestigated (CYP1A2, CYP2A6, CYP2B6, CYP2C918, CYP2C19, CYP2D6, CYP2E1
and CYP3A), at concentrations up to 250 mu M. 5 Studies using chemica
l inhibitors selective for individual P450 enzymes indicated the invol
vement of cytochrome P450 3A (CYP3A), both pathways of granisetron met
abolism being very sensitive to ketoconazole inhibition. Correlation d
ata were consistent with the role of CYP3A3/4 in granisetron 9'-desmet
hylation but indicated that a different enzyme was involved in the 7-h
ydroxylation.